{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:32:04Z","timestamp":1757590324317},"reference-count":5,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":11064,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1977,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Normocalcaemia was restored and maintained in eleven hypoparathyroid and two pseudohypoparathyroid patients treated for up to 36 months with 1\u03b1\u2010hydroxy\u2010vitamin D<jats:sub>3<\/jats:sub>. It was found to be a potent compound, maintenance doses rangmg from <jats:italic>4\u03bcg<\/jats:italic> weekly to 2\u03bcg daily. Supplementary oral calcium was used in acutely and profoundly hypocalcaemic patients but was given to only two patients as part of long\u2010term therapy. Hypercalcaemic episodes occurring during treatment were of short duration and could be controlled by withdrawal of medication alone.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1977.tb03382.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T13:33:50Z","timestamp":1205760830000},"source":"Crossref","is-referenced-by-count":8,"title":["1\u03b1\u2010HYDROXYVITAMIN D<sub>3<\/sub> IN THE LONG\u2010TERM MANAGEMENT OF H YPOP A R ATH Y ROIDISM AND PSEUDOHYPOPARATHYROIDISM"],"prefix":"10.1111","volume":"7","author":[{"given":"I. G.","family":"LEWIN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"PAPAPOULOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L. H.","family":"O'RIORDAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91077-7"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb03823.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92538-6"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(75)90055-4"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91348-8"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1977.tb03382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1977.tb03382.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:30:34Z","timestamp":1695727834000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1977.tb03382.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,12]]},"references-count":5,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1977,12]]}},"alternative-id":["10.1111\/j.1365-2265.1977.tb03382.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1977.tb03382.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,12]]}}}